T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
29 hedge funds and large institutions have $224M invested in T2 Biosystems, Inc in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$64.3M |
| 2 |
AC
Aisling Capital
New York
|
+$47M |
| 3 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
+$44.2M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$23.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.5M |
Top Sellers
TTOO Hedge Fund Activity: Q3 2014 in Review
29 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2014, worth a combined $224M.
Buyers outnumbered sellers: 29 funds opened new TTOO positions and 0 closed out — a net gain of 29 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $64.3M.
- 29 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $224M of T2 Biosystems, Inc stock for Q3 2014.
- 29 funds opened new T2 Biosystems, Inc positions in Q3 2014 and 0 closed out, a net change of +29 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2014 was Goldman Sachs, an estimated $64.3M added.
Based on aggregated 13F filings for Q3 2014.